verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler chartwell rx, llc
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 100 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-532
Product ID 62135-532_3131e786-8a0d-233f-e063-6294a90ac12b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA020943
Listing Expiration 2026-12-31
Marketing Start 1998-11-25

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135532
Hyphenated Format 62135-532

Supplemental Identifiers

RxCUI
897584
UPC
0362135532307
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number NDA020943 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62135-532-30)
source: ndc

Packages (1)

62135-532-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62135-532-30)

Ingredients (1)

verapamil hydrochloride (100 mg/1)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3131e786-8a0d-233f-e063-6294a90ac12b", "openfda": {"upc": ["0362135532307"], "unii": ["V3888OEY5R"], "rxcui": ["897584"], "spl_set_id": ["18f6d349-8c5c-4443-ac65-16bf6619ecdc"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62135-532-30)", "package_ndc": "62135-532-30", "marketing_start_date": "20230330"}], "brand_name": "Verapamil Hydrochloride", "product_id": "62135-532_3131e786-8a0d-233f-e063-6294a90ac12b", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "62135-532", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "NDA020943", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19981125", "listing_expiration_date": "20261231"}